See also our related blog for the Pediatric Preclinical Testing Initiative.

Sunday, May 22, 2011

Congratulations, Sachiko and Monika !

Through careful, systematic investigation the work on the mechanism of proteosome inhibitor efficacy in medulloblastoma has been accepted for publication in the Journal of Neuro-Oncology.  As a matter of full disclosure, the lead to an important facet of this paper was in fact suggested by a Reviewer!  This study is co-first authored by Monika and Sachiko.  Other authors include Keller lab alumnists Tohru and Laura.
This work was supported by a research grant from the National Brain Tumor Society.  

[ 6/5/2011 update:  the paper is now online at here ]

Welcoming Emma!

We are excited to welcome recent college graduate Emma Cantor to our team!  Emma brings with her rich experiences in molecular biology research as a college student, medicosocial outreach to the youth community and pediatric and cancer care exposures.  Emma's Summer internship will include participation in the Childhood Cancer Registry for Familial and Sporadic Tumors [CCURE-FAST] tumor bank & registry as well as preclinical therapeutics studies.
in Emma's own words:

"My interest in pediatric oncology began during my high school years when I worked as a child life volunteer in the Children’s Hospital of Philadelphia Cancer Center.  Since then, I have continued to explore my interests in both medicine and pediatrics through EMT training and work as the Chief Pediatric Emergency Medicine Research Associate in the St. Louis Children’s Hospital.  After just graduating from Washington University in St. Louis (May 2011) with a BA in Biology and Anthropology, I am excited to return to my roots in the Northwest to join the Keller Lab."